Gian Luigi Gessa | Academic Influence

Gian Luigi Gessa's AcademicInfluence.com Rankings

Gian Luigi Gessa

Biology

#3116

World Rank

#4809

Historical Rank

Neuroscience

#328

World Rank

#344

Historical Rank

biology Degrees

Download Badge

Biology

Gian Luigi Gessa's Degrees

PhD Neuropsychopharmacology University of Cagliari

Why Is Gian Luigi Gessa Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Gian Luigi Gessa is a professor of Neuropsychopharmacology at the University of Cagliari, where he has led for a long time the Department of Neurosciences. He is the leader of the Italian group that studies drug addiction. He also directed the research groups of the National Research Council.

(See a Problem?)

Gian Luigi Gessa's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area (1985) (794)
Effects of moderate alcohol consumption on the central nervous system. (1998) (642)
Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. (1992) (504)
Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. (1998) (502)
Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. (2002) (474)
Microdialysis measurement of cortical and hippocampal acetylcholine release during sleep-wake cycle in freely moving cats (1995) (473)
Endocannabinoids Mediate Presynaptic Inhibition of Glutamatergic Transmission in Rat Ventral Tegmental Area Dopamine Neurons through Activation of CB1 Receptors (2004) (435)
Evidence for a gabaergic projection from the substantia nigra to the ventromedial thalamus and to the superior colliculus of the rat (1979) (393)
Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. (1998) (356)
Central functions of oxytocin (1991) (332)
Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence. (1993) (319)
Stress-induced increase in 3,4-dihydroxyphenylacetic acid (DOPAC) levels in the cerebral cortex and in n. accumbens: reversal by diazepam. (1978) (298)
The role of dopamine in the mechanism of action of antidepressant drugs. (2000) (297)
Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. (1987) (281)
Rapid depletion of serum tryptophan, brain tryptophan, serotonin and 5-hydroxyindoleacetic acid by a tryptophan-free diet. (1974) (276)
Free tryptophan in serum controls brain tryptophan level and serotonin synthesis. (1973) (270)
GAMMA-HYDROXYBUTYRIC ACID FOR TREATMENT OF ALCOHOL WITHDRAWAL SYNDROME (1989) (254)
Effect of psychotropic drugs on tryptophan concentration in the rat brain. (1971) (253)
Prefrontal Cortex Stimulation Induces 2-Arachidonoyl-Glycerol-Mediated Suppression of Excitation in Dopamine Neurons (2004) (245)
gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study. (1992) (238)
Apomorphine-induced penile erection and yawning: site of action in brain (1987) (227)
Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716. (1998) (224)
Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence. (2000) (224)
Ability of baclofen in reducing alcohol intake and withdrawal severity: I--Preclinical evidence. (2000) (221)
Selective blockade of dopamine D-1 receptors by SCH 23390 discloses striatal dopamine D-2 receptors mediating the inhibition of adenylate cyclase in rats. (1984) (214)
Ethanol stimulates the firing rate of nigral dopaminergic neurons in unanesthetized rats (1984) (211)
Anxiolytic-Like Properties of the Anandamide Transport Inhibitor AM404 (2006) (210)
Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice (1998) (202)
Δ9-Tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study (2002) (202)
Effect of the oral administration of tryptophan‐free amino acid mixtures on serum tryptophan, brain tryptophan and serotonin metabolism (1974) (202)
Induction of copulatory behavior in sexually inactive rats by naloxine. (1979) (200)
Mesolimbic dopaminergic decline after cannabinoid withdrawal. (1998) (196)
Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam. (2006) (195)
Sardinian alcohol-preferring rats: A genetic animal model of anxiety (1995) (194)
Adolescent exposure to cannabinoids induces long-Lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons (2004) (193)
Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity. (1979) (189)
Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers (2004) (186)
Oxytocin-induced penile erection and yawning: Site of action in the brain (1986) (183)
Ethanol markedly increases "GABAergic" neurosteroids in alcohol-preferring rats. (1999) (173)
Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release (2003) (172)
Effect of spontaneous ingestion of ethanol on brain dopamine metabolism. (1989) (170)
Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats (2002) (168)
Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. (1992) (163)
Low doses of ethanol inhibit the firing of neurons in the substantia nigra, pars reticulata: a GABAergic effect? (1985) (162)
Stimulation of serotonin synthesis by lithium. (1971) (161)
Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. (1995) (161)
Stimulation of dopamine synthesis in caudate nucleus by intrastriatal enkephalins and antagonism by naloxone. (1978) (160)
Sleep deprivation in the rat: an animal model of mania (1995) (160)
Role of brain monoamines in male sexual behavior. (1974) (156)
Paraventricular nucleus lesion prevents yawning and penile erection induced by apomorphine and oxytocin but not by ACTH in rats (1987) (155)
Buprenorphine: a controlled clinical trial in the treatment of opioid dependence. (2000) (155)
Biochemical and electrophysiologic evidence that propofol enhances GABAergic transmission in the rat brain. (1991) (150)
Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR 141716A. (1998) (144)
MDL 72222, a selective 5-HT3 receptor antagonist, suppresses voluntary ethanol consumption in alcohol-preferring rats. (1991) (144)
Mesolimbic dopaminergic reduction outlasts ethanol withdrawal syndrome: Evidence of protracted abstinence (1996) (134)
Rapid suppression of alcohol withdrawal syndrome by baclofen. (2002) (133)
THERAPEUTIC EFFICACY OF APOMORPHINE COMBINED WITH AN EXTRACEREBRAL INHIBITOR OF DOPAMINE RECEPTORS IN PARKINSON'S DISEASE (1979) (133)
Baclofen suppresses motivation to consume alcohol in rats (2003) (130)
Pharmacology and neurochemistry of apomorphine. (1978) (130)
Association between dopamine receptor genes and migraine without aura in a Sardinian sample (1998) (128)
Role of GABAB receptors in the sedative/hypnotic effect of γ-hydroxybutyric acid (2001) (127)
The oxytocin antagonist d(CH2)5Tyr(Me)-Orn8-vasotocin inhibits male copulatory behaviour in rats. (1988) (127)
Alcohol-preferring rats have fewer dopamine D2 receptors in the limbic system. (1992) (125)
Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex (2005) (122)
Oxytocin: an extremely potent inducer of penile erection and yawning in male rats. (1986) (122)
Rapid changes in GABA binding induced by stress in different areas of the rat brain (1981) (121)
Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal (1999) (116)
SELECTIVE INCREASE OF BRAIN DOPAMINE SYNTHESIS BY SULPIRIDE (1975) (115)
Suppression by baclofen of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats. (2003) (114)
Role of GABAB receptor in alcohol dependence: Reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics (2009) (114)
Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain (2000) (113)
Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence. (2000) (113)
Changes in brain serotonin metabolism associated with fasting and satiation in rats (1972) (112)
EVIDENCE THAT METHADONE BLOCKS DOPAMINE RECEPTORS IN THE BRAIN (1972) (112)
Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons (2006) (111)
Postsynaptic receptors are not essential for dopaminergic feedback regulation (1977) (111)
Gamma-Hydroxybutyric Acid for Treatment of Opiate Withdrawal Syndrome (1993) (111)
Differential effect of acute and chronic ethanol on dopamine metabolism in frontal cortex, caudate nucleus and substantia nigra. (1980) (111)
Induction of Sexual Excitement by the Action of Adrenocorticotrophic Hormone in Brain (1969) (109)
Suppressing effect of the cannabinoid CB1 receptor antagonist, SR147778, on alcohol intake and motivational properties of alcohol in alcohol-preferring sP rats. (2005) (107)
d(CH2)5Tyr(Me)-[Orn8]vasotocin, a potent oxytocin antagonist, antagonizes penile erection and yawning induced by oxytocin and apomorphine, but not by ACTH-(1-24). (1987) (107)
THE GABAB RECEPTOR AGONISTS BACLOFEN AND CGP 44532 PREVENT ACQUISITION OF ALCOHOL DRINKING BEHAVIOUR IN ALCOHOL-PREFERRING RATS (2002) (106)
Serotonin now: clinical implications of inhibiting its synthesis with para-chlorophenylalanine. (1970) (106)
Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A. (1997) (105)
Endocannabinoid system and alcohol addiction: Pharmacological studies (2005) (105)
Dissociation of Haloperidol, Clozapine, and Olanzapine Effects on Electrical Activity of Mesocortical Dopamine Neurons and Dopamine Release in the Prefrontal Cortex (2000) (105)
Structural requirements for bretylium and guanethidine-like activity. (1962) (103)
Haloperidol increases and apomorphine decreases striatal dopamine metabolism after destruction of striatal dopamine-sensitive adenylate cyclase by kainic acid (1977) (103)
Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: implications for the antiglaucoma properties of marihuana. (1998) (103)
Possible stimulatory role of brain dopamine in the copulatory behavior of male rats. (1974) (103)
Stress and β-carbolines decrease the density of low affinity gaba binding sites An effect reversed by diazepam (1984) (102)
Protective activation of the endocannabinoid system during ischemia in dopamine neurons (2006) (100)
Alcohol withdrawal in rats is associated with a marked fall in extraneuronal dopamine. (1992) (100)
Calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous self-administration in drug-naive mice (1992) (96)
Self-inhibitory dopamine receptors: their role in the biochemical and behavioral effects of low doses of apomorphine. (1978) (96)
Therapeutic gamma-hydroxybutyric acid monitoring in plasma and urine by gas chromatography-mass spectrometry. (1993) (95)
Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants (1990) (93)
Mechanism of the antialcohol effect of gamma-hydroxybutyric acid. (2000) (92)
Apomorphine and L-DOPA lower ejaculation threshold in the male rat (1978) (92)
Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study. (2002) (91)
Role of thalamic γ-aminobutyrate in motor functions: Catalepsy and ipsiversive turning after intrathalamic muscimol (1979) (91)
Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study (2002) (91)
Distribution of GABA(B) receptor mRNAs in the rat brain and peripheral organs. (1999) (88)
Alpha2‐adrenoceptor mediated co‐release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex (2004) (88)
Sex Differences in Alcohol Use Disorder. (2017) (87)
Animal models of mania. (1995) (87)
Decrease in plasma tryptophan after tryptophan-free amino acid mixtures in man. (1988) (87)
Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract. (2003) (86)
D2 dopamine receptors enable Δ9‐tetrahydrocannabinol induced memory impairment and reduction of hippocampal extracellular acetylcholine concentration (2000) (85)
Evidence that apomorphine induces penile erection and yawning by releasing oxytocin in the central nervous system. (1989) (85)
Dramatic Depletion of Mesolimbic Extracellular Dopamine after Withdrawal from Morphine, Alcohol or Cocaine: A Common Neurochemical Substrate for Drug Dependence (1992) (84)
Evidence that nigral GABA mediates behavioural responses elicited by striatal dopamine receptor stimulation. (1978) (84)
Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleus (2005) (84)
Depletion of mesolimbic dopamine during behavioral despair: partial reversal by chronic imipramine. (1993) (84)
Effects of cocaine and amphetamine on acetylcholine release in the hippocampus and caudate nucleus. (1993) (84)
Blockade by the cannabinoid CB1 receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring rats (2002) (83)
Baclofen-induced reduction of alcohol reinforcement in alcohol-preferring rats. (2005) (83)
Sedation and sleep induced by high doses of apomorphine after blockade of D-1 receptors by SCH 23390. (1985) (82)
Increase of brain tryptophan caused by drugs which stimulate serotonin synthesis. (1971) (82)
Rimonabant: the first therapeutically relevant cannabinoid antagonist. (2005) (82)
Stimulation of both dopamine D1 and D2 receptors facilitates in vivo acetylcholine release in the hippocampus (1993) (82)
Stress increases noradrenaline release in the rat frontal cortex: prevention by diazepam. (1990) (82)
Suppression by gamma-hydroxybutyric acid of ethanol withdrawal syndrome in rats. (1989) (81)
Cannabinoid modulation of intestinal propulsion in mice. (1998) (79)
Sex differences in substance use disorders: focus on side effects (2016) (77)
Antidepressant-like effect of ethanol revealed in the forced swimming test in Sardinian alcohol-preferring rats (1999) (76)
Effects of chronic Δ9-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze (2001) (76)
Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo (2005) (75)
Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex. (2004) (75)
Alcohol-preferring rats: Genetic sensitivity to alcohol-induced stimulation of dopamine metabolism (1990) (75)
Stretching and yawning movements after intracerebral injection of ACTH. (1967) (75)
Neuropeptides and sexual behaviour (1991) (75)
The cannabinoid receptor antagonist SR 141716 prevents acquisition of drinking behavior in alcohol-preferring rats. (2001) (75)
(—)-Sulpiride activates the firing rate and tyrosine hydroxylase activity of dopaminergic neurons in unanesthetized rats (1983) (74)
Circadian drinking pattern of Sardinian alcohol-preferring rats. (1996) (74)
Inhibition of copulatory behavior in male rats by D-Ala2-Met-enkephalinamide. (1978) (73)
Behavioral and vegetative effects produced by dibutyryl cyclic AMP injected into different areas of the brain. (1970) (73)
Specific reduction of alcohol's motivational properties by the positive allosteric modulator of the GABAB receptor, GS39783--comparison with the effect of the GABAB receptor direct agonist, baclofen. (2008) (73)
Depression and mania : from neurobiology to treatment (1995) (72)
Dopamine receptors mediating yawning: are they autoreceptors? (1986) (72)
Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal (2002) (71)
Sedative, hypnotic, and antipsychotic effects of low doses of apomorphine in man. (1977) (71)
Low doses of γ-hydroxybutyric acid stimulate the firing rate of dopaminergic neurons in unanesthetized rats (1991) (70)
Baclofen attenuates cue-induced reinstatement of alcohol-seeking behavior in Sardinian alcohol-preferring (sP) rats. (2008) (70)
Quantitative autoradiographic distribution of gamma-hydroxybutyric acid binding sites in human and monkey brain. (2000) (69)
Inhibition of hippocampal acetylcholine release after acute and repeated Δ9-tetrahydrocannabinol in rats (1998) (68)
Disappearance of cerebellar cyclic GMP induced by kainic acid (1978) (68)
Selective MPP+ uptake into synaptic dopamine vesicles: possible involvement in MPTP neurotoxicity (1993) (67)
Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids. (1998) (67)
Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic (2003) (67)
Delineating the psychic structure of substance abuse and addictions: should anxiety, mood and impulse-control dysregulation be included? (2010) (66)
Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid. (2001) (66)
Chronic morphine and naltrexone fail to modify mu-opioid receptor mRNA levels in the rat brain. (1997) (65)
Comparison of the effect of the GABAΒ receptor agonist, baclofen, and the positive allosteric modulator of the GABAB receptor, GS39783, on alcohol self-administration in 3 different lines of alcohol-preferring rats. (2012) (65)
Stimulation of locomotor activity by voluntarily consumed ethanol in Sardinian alcohol-preferring rats. (1998) (65)
Gamma-hydroxybutyric acid reducing effect on ethanol intake: evidence in favour of a substitution mechanism. (1998) (65)
Baclofen suppresses alcohol intake and craving for alcohol in a schizophrenic alcohol-dependent patient: a case report. (2007) (65)
Symmetrical generalization between the discriminative stimulus effects of gamma-hydroxybutyric acid and ethanol: Occurrence within narrow dose ranges (1995) (65)
Selective γ‐hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative/hypnotic effect of γ‐hydroxybutyric acid (2003) (64)
Essential Role of Testosterone in the Sexual Stimulation induced by p-Chlorophenylalanine in Male Animals (1970) (64)
Central effects of 1,4-butanediol are mediated by GABAB receptors via its conversion into γ-hydroxybutyric acid (2002) (64)
Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants. (1990) (63)
Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats (2008) (63)
Reduction of alcohol's reinforcing and motivational properties by the positive allosteric modulator of the GABA(B) receptor, BHF177, in alcohol-preferring rats. (2009) (62)
Apomorphine hydrochloride-induced improvement in Huntington's chorea: stimulation of dopamine receptor. (1978) (62)
A simple radioenzymatic method for determination of picogram amounts of 3,4‐dihydroxyphenylacetic acid (DOPAC) in the rat brain (1977) (62)
Reserpine and guanethidine action on peripheral stores of catecholamines. (1962) (61)
Alcohol stimulates motor activity in selectively bred Sardinian alcohol-preferring (sP), but not in Sardinian alcohol-nonpreferring (sNP), rats. (2001) (61)
Modulation of basal and stress-induced release of acetylcholine and dopamine in rat brain by abecarnil and imidazenil, two anxioselective gamma-aminobutyric acidA receptor modulators. (1995) (61)
Suppressing effect of the cannabinoid CB1 receptor antagonist, SR 141716, on alcohol's motivational properties in alcohol-preferring rats. (2004) (61)
Baclofen-induced suppression of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats exposed to different alcohol concentrations. (2006) (61)
Reducing effect of the positive allosteric modulators of the GABA(B) receptor, CGP7930 and GS39783, on alcohol intake in alcohol-preferring rats. (2005) (61)
Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair animal model of depression. (1994) (61)
Effect of muscimol, a GABA-mimetic agent, on dopamine metabolism in the mouse brain. (1977) (60)
Suppression of voluntary ethanol consumption in rats by gamma-butyrolactone. (1983) (60)
Possible role of brain serotonin and dopamine in controlling male sexual behavior. (1974) (59)
Apomorphine stimulation of male copulatory behavior is prevented by the oxytocin antagonist d(CH2)5Tyr(Me)-Orn8-vasotocin in rats (1989) (58)
Cross-tolerance to ethanol and γ-hydroxybutyric acid (1995) (58)
Increase in alcohol intake, reduced flexibility of alcohol drinking, and evidence of signs of alcohol intoxication in Sardinian alcohol-preferring rats exposed to intermittent access to 20% alcohol. (2010) (58)
Cannabinoid Receptor Antagonists Counteract Sensorimotor Gating Deficits in the Phencyclidine Model of Psychosis (2007) (58)
Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex (2003) (57)
Potential use of medicinal plants in the treatment of alcoholism. (2000) (56)
On the mechanism of norepinephrine release by α-methyl-metatyrosine (1962) (56)
Reducing effect of the positive allosteric modulator of the GABAB receptor, GS39783, on alcohol self-administration in alcohol-preferring rats (2007) (55)
Maintaining abstinence from alcohol with γ-hydroxybutyric acid (1998) (55)
Development of short-lasting alcohol deprivation effect in sardinian alcohol-preferring rats. (2000) (55)
Possible role of free serum tryptophan in the control of brain tryptophan level and serotonin synthesis. (1974) (55)
GABAB receptor-mediated increase of neurosteroids by γ-hydroxybutyric acid (2002) (54)
Marked decrease of A10 dopamine neuronal firing during ethanol withdrawal syndrome in rats. (1992) (54)
Stress-induced insomnia: opioid-dopamine interactions. (1987) (54)
REM sleep deprivation induces subsensitivity of dopamine receptors mediating sedation in rats. (1981) (54)
Selective inhibition of serotonin uptake by trazodone, a new antidepressant agent. (1976) (54)
Corticotropin-releasing factor (CRF) increases paradoxical sleep (PS) rebound in PS-deprived rats (1990) (53)
Isradipine inhibits nicotine intravenous self-administration in drug-naive mice (1995) (53)
Lack of tolerance to ethanol-induced stimulation of mesolimbic dopamine system. (1992) (52)
Involvement of GABAA and GABAB receptors in the mediation of discriminative stimulus effects of γ-hydroxybutyric acid (1998) (52)
SCH 23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphine. (1985) (52)
Differential effect of psychotropic drugs on dihydroxyphenylacetic acid (DOPAC) in the rat substantia nigra and caudate nucleus. (1977) (52)
Isradipine and other calcium channel antagonists attenuate ethanol consumption in ethanol-preferring rats. (1992) (52)
Antipsychotic-Like Properties of 5-α-Reductase Inhibitors (2008) (51)
Inhibition of hippocampal acetylcholine release by benzodiazepines: antagonism by flumazenil. (1993) (51)
Involvement of arginine vasopressin and V1b receptor in alcohol drinking in Sardinian alcohol-preferring rats. (2011) (51)
Intravenous self-administration of gamma-hydroxybutyric acid in drug-naive mice (1998) (50)
Failure of ketamine to interact with opiate receptors. (1980) (50)
Effect of apomorphine on oxytocin concentrations in different brain areas and plasma of male rats. (1990) (50)
Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid. (2002) (49)
Short-term endogenous hyperprolactinaemia and sexual behavior of male rats (1981) (49)
Gamma-hydroxybutyric acid in the treatment of alcoholism: dosage fractioning utility in non-responder alcoholic patients. (1998) (49)
Sub‐chronic treatment with classical but not atypical antipsychotics produces morphological changes in rat nigro‐striatal dopaminergic neurons directly related to ‘early onset’ vacuous chewing (2002) (48)
Operant self-administration of ethanol in Sardinian alcohol-preferring rats. (2002) (48)
Benzodiazepine-induced voraciousness in cats and inhibition of amphetamine-anorexia. (1976) (48)
Efficacy of rimonabant and other cannabinoid CB1 receptor antagonists in reducing food intake and body weight: preclinical and clinical data. (2006) (47)
Evidence for dopamine autoreceptors in mesocortical dopamine neurons (1984) (47)
The CB receptor agonist WIN 55,212-2 fails to elicit disruption of prepulse inhibition of the startle in Sprague-Dawley rats (2004) (46)
In vivo effectiveness of CGP7930, a positive allosteric modulator of the GABAB receptor. (2004) (46)
Intraventricular oxytocin induces yawning and penile erection in rats. (1985) (46)
Blockade of the discriminative stimulus effects of γ-hydroxybutyric acid (GHB) by the GHB receptor antagonist NCS-382 (1995) (45)
The GABA(B) receptor agonists baclofen and CGP 44532 prevent acquisition of alcohol drinking behaviour in alcohol-preferring rats. (2002) (45)
Stimulation of dopamine autoreceptors elicits “premature ejaculation” in rats (1984) (45)
Inhibition of peristaltic activity by cannabinoids in the isolated distal colon of mouse. (2001) (45)
Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head‐restrained rat (2003) (45)
Reduction of dopamine release and synthesis by repeated amphetamine treatment: role in behavioral sensitization. (1996) (44)
Baclofen reverses the reduction in prepulse inhibition of the acoustic startle response induced by dizocilpine, but not by apomorphine (2004) (44)
Extraneuronal noradrenaline in the prefrontal cortex of morphine-dependent rats: tolerance and withdrawal mechanis (1993) (44)
Reducing effect of a Phaseolus vulgaris dry extract on food intake, body weight, and glycemia in rats. (2009) (43)
Disulfiram stimulates dopamine release from noradrenergic terminals and potentiates cocaine-induced dopamine release in the prefrontal cortex (2012) (43)
Gamma-Hydroxybutyrate Reduces both Withdrawal Syndrome and Hypercortisolism in Severe Abstinent Alcoholics: An Open Study vs. Diazepam (2007) (42)
Spontaneous bursting activity of dopaminergic neurons in midbrain slices from immature rats: role of N-methyl-d-aspartate receptors (1997) (42)
Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistas. (1999) (42)
Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors. (1993) (42)
Brain dialysis provides evidence for D2-dopamine receptors modulating noradrenaline release in the rat frontal cortex. (1989) (41)
Oral self-administration of γ-hydroxybutyric acid in the rat (1995) (41)
Brain dialysis and dopamine: does the extracellular concentration of dopamine reflect synaptic release? (1990) (41)
Neonatal hypothyroidism induces striatal dopaminergic dysfunction (1990) (41)
Evidence that hyperthermia produced by d-amphetamine is caused by a peripheral action of the drug. (1969) (41)
Permissive Role of Dopamine D2 Receptors in the Hypothermia Induced by Δ9-Tetrahydrocannabinol in Rats (2000) (40)
Possible Mechanism of Antidepressant Effect of l‐Sulpiride (1990) (40)
The positive allosteric modulator of the GABA(B) receptor, rac-BHFF, suppresses alcohol self-administration. (2010) (40)
The benzodiazepine receptor antagonist flumazenil increases acetylcholine release in rat hippocampus (1994) (40)
Effect of methadone and dextromoramide on dopamine metabolism: Comparison with haloperidol and amphetamine (1975) (40)
Kappa Opioid Receptor Activation Disrupts Prepulse Inhibition of the Acoustic Startle in Rats (2005) (39)
Investigation on the relationship between cannabinoid CB1 and opioid receptors in gastrointestinal motility in mice (2006) (39)
Sex differences in the response to opioids for pain relief: A systematic review and meta-analysis. (2019) (39)
Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo (2007) (39)
γ-Hydroxybutyric acid and baclofen decrease extracellular acetylcholine levels in the hippocampus via GABAB receptors☆ (2001) (39)
Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase activity in rat hippocampus. (1987) (39)
Opposite effects of stress on dopamine release in the limbic system of drug-naive and chronically amphetamine-treated rats. (1997) (38)
Suppression by baclofen of the stimulation of alcohol intake induced by morphine and WIN 55,212-2 in alcohol-preferring rats. (2004) (38)
Δ9‐Tetrahydrocannabinol increases sequence‐specific AP‐1 DNA‐binding activity and Fos‐related antigens in the rat brain (1998) (38)
Sleep deprivation disrupts prepulse inhibition of the startle reflex: reversal by antipsychotic drugs. (2008) (38)
Prohibition of take-home dosages: negative consequences on methadone maintenance treatment. (1996) (38)
Serotonin is reduced in the frontal cortex of Sardinian ethanol-preferring rats. (1998) (38)
Efficacy and Tolerability of Baclofen in Substance Use Disorders: A Systematic Review (2013) (38)
The R100Q mutation of the GABA(A) alpha(6) receptor subunit may contribute to voluntary aversion to ethanol in the sNP rat line. (2001) (37)
N-n-propyl-norapomorphine: An extremely potent stimulant of dopamine autoreceptors (1982) (37)
Characterization of COR627 and COR628, Two Novel Positive Allosteric Modulators of the GABAB Receptor (2012) (37)
Nimodipine inhibits cocaine-induced dopamine release and motor stimulation. (1990) (37)
Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2. (2007) (37)
γ-Hydroxybutyrate inhibits excitatory postsynaptic potentials in rat hippocampal slices (1999) (37)
Biphasic effect of ethanol on noradrenaline release in the frontal cortex of awake rats. (1992) (37)
Possible role of insulin in the transport of tyrosine and tryptophan from blood to brain. (1976) (36)
Cocaine releases limbic acetylcholine through endogenous dopamine action on D1 receptors. (1992) (36)
Blockade by the cannabinoid CB(1) receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring rats. (2002) (35)
Repeated treatment with imipramine potentiates cocaine-induced dopamine release and motor stimulation. (1991) (35)
Psychiatric severity and treatment response in a comprehensive methadone maintenance treatment program. (1997) (35)
Stable preference for high ethanol concentrations after ethanol deprivation in Sardinian alcohol-preferring (sP) rats. (2003) (35)
Effects of the calcium channel antagonist darodipine on ethanol withdrawal in rats. (1995) (35)
Suppression of voluntary alcohol intake in rats and alcoholics by gamma-hydroxybutyric acid: a non-GABAergic mechanism. (1992) (35)
Boosting effect of morphine on alcohol drinking is suppressed not only by naloxone but also by the cannabinoid CB1 receptor antagonist, SR 141716. (2002) (34)
γ‐Hydroxybutyrate modulation of glutamate levels in the hippocampus: an in vivo and in vitro study (2001) (34)
Reduced [3H]SCH 23390 binding and DA-sensitive adenylyl cyclase in the limbic system of ethanol-preferring rats. (1993) (34)
Sardinian alcohol-preferring rats prefer chocolate and sucrose over ethanol. (1997) (34)
Ro 19-4603, a benzodiazepine receptor inverse agonist, attenuates voluntary ethanol consumption in rats selectively bred for high ethanol preference. (1990) (34)
Increase in stage 4 sleep after ingestion of a tryptophan-free diet in humans. (1984) (34)
Dissociation of ethanol and saccharin preference in sP and sNP rats. (2000) (34)
Dopamine and opioids interactions in sleep deprivation (1993) (33)
Effects of acute, chronic ethanol and withdrawal on dorsal raphe neurons: electrophysiological studies (1997) (33)
Synthesis and biological evaluation of 1,8-naphthyridin-4(1H)-on-3-carboxamide derivatives as new ligands of cannabinoid receptors. (2004) (33)
Neuroprotective effect of γ-hydroxybutyrate in transient global cerebral ischemia in the rat (2000) (33)
Protection against ethanol mortality in rats by the imidazobenzodiazepine RO 15-4513. (1987) (32)
Different sensitivity to ethanol in alcohol-preferring sP and -nonpreferring sNP rats. (2000) (32)
Synthesis and pharmacological characterization of 2-(acylamino)thiophene derivatives as metabolically stable, orally effective, positive allosteric modulators of the GABAB receptor. (2013) (32)
Autoreceptors mediate the inhibition of dopamine synthesis by bromocriptine and lisuride in rats. (1983) (32)
Lack of acute antipsychotic effect of Sch 23390, a selective dopamine D1 receptor antagonist (1991) (31)
INCREASE OF BRAIN TRYPTOPHAN BY ELECTROCONVULSIVE SHOCK IN RATS (1972) (31)
Contribution of GABAA and GABAB Receptors to the Discriminative Stimulus Produced by Gamma-Hydroxybutyric Acid (1999) (31)
Salvia miltiorrhiza extract inhibits alcohol absorption, preference, and discrimination in sP rats. (1999) (31)
γ-Aminobutyric AcidB (GABAB)-Receptor Mediation of Different In Vivo Effects of γ-Butyrolactone (2008) (31)
On mechanisms of norepinephrine release by amphetamine and tyramine and tolerance to their effects. (1969) (30)
Different epileptogenic activities of murine and ovine corticotropin-releasing factor (1987) (30)
Dopamine D1 and opioid receptor binding changes in the limbic system of sleep deprived rats (1992) (30)
GAMMA‐HYDROXYBUTYRIC ACID IN THE TREATMENT OF ALCOHOL DEPENDENCE (1992) (30)
ω-Conotoxin prevents apomorphine- and oxytocin-induced penile erection and yawning in male rats (1990) (30)
Interaction of metergoline with striatal dopamine system. (1978) (30)
γ-Hydroxybutyric Acid Intake in Ethanol-preferring sP and -nonpreferring sNP Rats (1998) (30)
Homosexual mounting behavior induced in male rats and rabbits by a tryptophan-free diet. (1977) (30)
Does dopamine exert a tonic inhibitory control on the release of striatal acetylcholine in vivo? (1994) (30)
Brain nucleotides in naive and handling-habituated rats: differences in levels and drug-sensitivity (1980) (29)
Chronic imipramine reduces [3H]SCH 23390 binding and DA-sensitive adenylate cyclase in the limbic system. (1989) (29)
Identification of miltirone as active ingredient of Salvia miltiorrhiza responsible for the reducing effect of root extracts on alcohol intake in rats. (2006) (29)
The central cholinergic system has a role in the antinociception induced in rodents and guinea pigs by the antimigraine drug sumatriptan. (1996) (29)
IDN 5082, a standardized extract of Salvia miltiorrhiza, delays acquisition of alcohol drinking behavior in rats. (2003) (29)
Differences in ethanol-induced conditioned taste aversion in Sardinian alcohol-preferring and Sardinian alcohol-nonpreferring rats. (2002) (29)
SCH 23390, a selective D1 dopamine receptor blocker, enhances the firing rate of nigral dopaminergic neurons but fails to activate striatal tyrosine hydroxylase (1985) (29)
Rapid tolerance to the intestinal prokinetic effect of cannabinoid CB1 receptor antagonist, SR 141716 (Rimonabant). (2004) (29)
Ethanol withdrawal does not induce a reduction in the number of spontaneously active dopaminergic neurons in the mesolimbic system (1995) (29)
Reduction of alcohol intake by the positive allosteric modulator of the GABA(B) receptor, rac-BHFF, in alcohol-preferring rats. (2013) (29)
Naloxone antagonizes ethanol- but not α-hydroxybutyrate-induced sleep in mice (1994) (28)
Effects of voluntary alcohol drinking on corticotropin-releasing factor and preprodynorphin mRNA levels in the central amygdala of Sardinian alcohol-preferring rats (2013) (28)
Activation of GABA(B) receptors reverses spontaneous gating deficits in juvenile DBA/2J mice. (2007) (28)
Stimulation of brain serotonin turnover by paradoxical sleep deprivation in intact and hypophysectomized rats. (1973) (28)
The dopamine beta‐hydroxylase inhibitor nepicastat increases dopamine release and potentiates psychostimulant‐induced dopamine release in the prefrontal cortex (2014) (28)
Clozapine potently stimulates mesocortical dopamine neurons. (1999) (28)
Dopamine D2 receptor antagonists prevent Δ9-tetrahydrocannabinol-induced antinociception in rats (1999) (28)
Biochemical and electrophysiological effects of 7‐OH‐DPAT on the mesolimbic dopaminergic system (1995) (28)
Selective adenylate cyclase increase in the limbic area of long-term imipramine-treated rats. (1990) (27)
γ-Hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: Evidence for GABAB receptor-mediated effects (2005) (27)
Denervation supersensitivity for benzodiazepine receptors in the rat substantia nigra (1981) (27)
Constant absolute ethanol intake by Sardinian alcohol-preferring rats independent of ethanol concentrations. (1997) (27)
(-)S amisulpride binds with high affinity to cloned dopamine D(3) and D(2) receptors. (2001) (27)
Ethanol prevents stress-induced increase in cortical DOPAC: Reversal by RO 15–4513 (1987) (27)
Autoradiographic analysis of 5-HT2A binding sites in the brain of Sardinian alcohol-preferring and nonpreferring rats. (1999) (27)
Inhibition of alcohol self-administration by positive allosteric modulators of the GABAB receptor in rats: lack of tolerance and potentiation of baclofen (2015) (27)
Multiple cycles of repeated treatments with a Phaseolus vulgaris dry extract reduce food intake and body weight in obese rats. (2011) (26)
Haloperidol-induced vacuous chewing in rats: suppression by α-methyl-tyrosine (1992) (26)
Resuscitative Effect of a γ-Aminobutyric Acid B Receptor Antagonist on γ-Hydroxybutyric Acid Mortality in Mice (2005) (26)
Haloperidol does not produce dopamine cell depolarization-block in paralyzed, unanesthetized rats (1998) (26)
Efficacy of Medications Approved for the Treatment of Alcohol Dependence and Alcohol Withdrawal Syndrome in Female Patients: A Descriptive Review (2015) (25)
R(+)-Baclofen, but Not S(−)-Baclofen, Alters Alcohol Self-Administration in Alcohol-Preferring Rats (2016) (25)
Suppression by progabide of ethanol withdrawal syndrome in rats. (1985) (25)
Apomorphine increases plasma oxytocin concentration in male rats (1989) (25)
Chronic morphine increases hippocampal acetylcholine release: possible relevance in drug dependence. (1996) (24)
Dynamic aspects of neurohormonal control of cyclic 3',5'-AMP synthesis in brain. (1970) (24)
Estrogens antagonize apomorphine-induced yawning in rats. (1984) (24)
INHIBITION BY APOMORPHINE OF DOPAMINE DEAMINATION IN THE RAT BRAIN (1974) (24)
Stimulation of "regulatory" dopamine receptors by bromocriptine (CB-154). (1978) (24)
Failure of chronic haloperidol to induce depolarization inactivation of dopamine neurons in unanesthetized rats. (1994) (23)
Reduced TH-immunoreactive fibers in the limbic system of Sardinian alcohol-preferring rats (2002) (23)
Suppressing Effect of Baclofen on Multiple Alcohol-Related Behaviors in Laboratory Animals (2018) (23)
Anti-relapse properties of IDN 5082, a standardized extract of Salvia miltiorrhiza, in alcohol-preferring rats. (2003) (23)
Selective inhibition of poliovirus growth by d-Penicillamine in vitro. (1966) (23)
Possible role of insulin in the transport of tyrosine and tryptophan from blood to brain (1975) (23)
Permissive role of dopamine D(2) receptors in the hypothermia induced by delta(9)-tetrahydrocannabinol in rats. (2000) (23)
GABAB-receptor mediation of the inhibitory effect of γ-hydroxybutyric acid on intestinal motility in mice (2002) (23)
Interaction between Menstrual Cyclicity and Gonadotropin Pulsatility (1998) (23)
Kainic acid differentiates GABA receptors from benzodiazepine receptors in the rat cerebellum (1980) (23)
Lack of tolerance to ethanol-induced dopamine release in the rat ventral striatum. (1993) (23)
Voluntary alcohol drinking enhances proopiomelanocortin gene expression in nucleus accumbens shell and hypothalamus of Sardinian alcohol-preferring rats. (2013) (23)
Maintaining abstinence from alcohol with gamma-hydroxybutyric acid. (1998) (22)
The NMDA receptor antagonist MK-801 prevents imipramine-induced supersensitivity to quinpirole. (1992) (22)
Selective gamma-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative/hypnotic effect of gamma-hydroxybutyric acid. (2003) (22)
Changes in dopamine metabolism associated with fasting and satiation. (1977) (22)
Daily changes of free serum tryptophan in humans. (1974) (22)
Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB₁ cannabinoid receptors. (2010) (22)
Effect of ethanol on extracellular 5-hydroxytryptamine output in rat frontal cortex. (1994) (22)
Gamma-hydroxybutyrate Reduces GABAA-mediated Inhibitory Postsynaptic Potentials in the CA1 Region of Hippocampus (2002) (22)
Effect of the combination of naltrexone and baclofen, on acquisition of alcohol drinking behavior in alcohol-preferring rats. (2005) (22)
Reducing effect of a Phaseolus vulgaris dry extract on operant self-administration of a chocolate-flavoured beverage in rats (2010) (21)
Suppression of REM and delta sleep by apomorphine in man: A dopamine mimetic effect (2004) (21)
Selective inhibition of dopamine‐beta‐hydroxylase enhances dopamine release from noradrenergic terminals in the medial prefrontal cortex (2015) (21)
GABA(B) receptor-mediated increase of neurosteroids by gamma-hydroxybutyric acid. (2002) (21)
Methamphetamine Induces Long-Term Alterations in Reactivity to Environmental Stimuli: Correlation with Dopaminergic and Serotonergic Toxicity (2009) (21)
Neuroprotective effect of gamma-hydroxybutyrate in transient global cerebral ischemia in the rat. (2000) (21)
HIGH SENSITIVITY TO λ-HYDROXYBUTYRIC ACID IN ETHANOL-PREFERRING sP RATS (1998) (20)
Low responsiveness to agents evoking 5-HT2 receptor-mediated behaviors in Sardinian alcohol-preferring rats (1995) (20)
Effects of Topiramate on the Prepulse Inhibition of the Acoustic Startle in Rats (2007) (20)
Stereoselectivity of NCS-382 binding to γ-hydroxybutyrate receptor in the rat brain (2002) (20)
Central effects of 1,4-butanediol are mediated by GABA(B) receptors via its conversion into gamma-hydroxybutyric acid. (2002) (20)
Evolution of the dopaminergic system and its relationships with the psychopathology of pleasure. (1997) (20)
Indirect activation of the DA system as a possible mechanism for the stimulatory effects of narcotic analgesics. (1977) (20)
Stimulation by dibutyryl cyclic AMP of serotonin synthesis and tryptophan transport in brain slices. (1972) (20)
Dopamine synthesis: tolerance to haloperidol and supersensitivity to apomorphine depend on presynaptic receptors. (1980) (19)
Blockade by apomorphine of haloperidol-induced dyskinesia in schizophrenic patients. (1972) (19)
Ethanol-stress interaction on dopamine metabolism in the medial prefrontal cortex. (1985) (19)
Destruction of post-synaptic dopamine receptors prevents neuroleptic-induced activation of striatal tyrosine hydroxylase but not dopamine synthesis stimulation. (1978) (19)
Reduction by the Positive Allosteric Modulator of the GABAB Receptor, GS39783, of Alcohol Self-Administration in Sardinian Alcohol-Preferring Rats Exposed to the “Sipper” Procedure (2010) (19)
Neuroleptics cause stimulation of dopamine D1 receptors and their desensitization after chronic treatment. (1994) (19)
Flunarizine potentiates cocaine-induced dopamine release and motor stimulation in rats. (1990) (19)
Alcohol use disorders, and at-risk drinking in patients affected by a mood disorder, in Cagliari, Italy: sensitivity and specificity of different questionnaires. (2007) (19)
Activation of the GABAB Receptor Prevents Nicotine-Induced Locomotor Stimulation in Mice (2011) (19)
Interaction of 1‐methyl‐4‐phenylpyridinium ion and tyramine with a site putatively involved in the striatal vesicular release of dopamine (1991) (19)
Reduced DAT- and DBH-immunostaining in the limbic system of Sardinian alcohol-preferring rats (2002) (19)
GABA(B) receptor inhibition causes locomotor stimulation in mice. (2001) (19)
Substantia nigra as an out-put station for striatal dopaminergic responses: Role of a GABA-mediated inhibition of pars reticulata neurons (1979) (18)
gamma-Hydroxybutyric acid and baclofen decrease extracellular acetylcholine levels in the hippocampus via GABA(B) receptors. (2001) (18)
Evidence that the loss of brain catecholamine stores due to blockade of storage does not cause sedation. (1962) (18)
Gamma‐hydroxybutyric acid in alcohol preference, dependence and withdrawal (2000) (18)
Involvement of GABA(A) and GABA(B) receptors in the mediation of discriminative stimulus effects of gamma-hydroxybutyric acid. (1998) (18)
Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: evidence for GABA(B) receptor-mediated effects. (2005) (18)
The development of medications for alcohol-use disorders targeting the GABAB receptor system. (2012) (18)
Binge drinking in alcohol-preferring sP rats at the end of the nocturnal period. (2014) (17)
Gamma-Hydroxybutyrate inhibits excitatory postsynaptic potentials in rat hippocampal slices. (1999) (17)
Gamma-Hydroxybutyric Acid Decreases Intravenous Cocaine Self-Administration in Rats (1998) (17)
High alcohol intake in female Sardinian alcohol-preferring rats. (2014) (17)
Endogenous γ-hydroxybutyric acid is in the rat, mouse and human gastrointestinal tract (2003) (17)
Resuscitative effect of a gamma-aminobutyric acid B receptor antagonist on gamma-hydroxybutyric acid mortality in mice. (2005) (17)
Bromocriptine: a rather specific stimulant of dopamine receptors regulating dopamine metabolism. (1977) (17)
Cue-induced reinstatement of ethanol seeking in Sardinian alcohol-preferring rats. (2007) (17)
Oxytocin-induced penile erection and yawning: Role of calcium and prostaglandins (1990) (17)
Protective effect of Panax ginseng in cisplatin-induced cachexia in rats. (2014) (17)
Oral self-administration of gamma-hydroxybutyric acid in the rat. (1995) (16)
Tryptophan metabolism in male Sardinian alcohol-preferring (sP) and -non-preferring (sNP) rats. (1998) (16)
Sudden decrease in cerebellar GABA binding induced by stress. (1980) (16)
Calcium channel inhibitors prevent apomorphine- and oxytocin-induced penile erection and yawning in male rats. (1989) (16)
Endogenous γ-aminobutyric acid (GABA)A receptor active neurosteroids and the sedative/hypnotic action of γ-hydroxybutyric acid (GHB): A study in GHB-S (sensitive) and GHB-R (resistant) rat lines (2005) (16)
Gamma-aminobutyric acidB (GABAB)-receptor mediation of different in vivo effects of gamma-butyrolactone. (2008) (16)
Disulfiram for binge eating disorder: an open trail. (2015) (16)
Aphrodisiac effect ofl-DOPA and apomorphine in male sexually sluggish rats (1974) (16)
Blockade of ethanol discrimination by isradipine. (1994) (16)
Peripheral dopamine receptors in the antihypertensive action of dihydroergotoxine in humans. (1987) (16)
Operant, oral alcohol self-administration: Sex differences in Sardinian alcohol-preferring rats. (2019) (16)
Differential effects of abecarnil on basal release of acetylcholine and dopamine in the rat brain. (1994) (16)
Suppressing effect of COR659 on alcohol, sucrose, and chocolate self-administration in rats: involvement of the GABAB and cannabinoid CB1 receptors (2017) (15)
Anxiety-like behaviors at the end of the nocturnal period in sP rats with a "history" of unpredictable, limited access to alcohol. (2015) (15)
Dizocilpine prevents the enhanced locomotor response to quinpirole induced by repeated electroconvulsive shock. (1997) (15)
Chronic haloperidol: tolerance to the stimulating effect on striatal tyrosine hydroxylase. (1979) (15)
Role of Brain Monoamines in Male Sexual Behavior (1975) (15)
Elevated dopamine in the medial prefrontal cortex suppresses cocaine seeking via D1 receptor overstimulation (2016) (15)
Proconvulsive effect of the GABA(B) receptor antagonist, SCH 50911, in rats undergoing ethanol withdrawal syndrome. (2002) (15)
Effect of the amisulpride isomers on rat catalepsy. (2002) (14)
Antagonism of the guanidine interference with poliovirus replication by simple methylated and ethylated compounds. (1966) (14)
Hypophysectomy prevents ACTH-induced yawning and penile erection in rats (1987) (14)
Inhibition by lithium of dopamine‐sensitive adenylate‐cyclase in the rat brain (1978) (14)
Alcohol use disorders in primary care patients in Cagliari, Italy. (2006) (14)
Chronic haloperidol causes persistent increase in 3,4-dihydroxyphenylacetic acid (DOPAC) concentration in the substantia nigra but not in the ventral tegmental area (1979) (14)
Influence of hypothermia on chlorpromazine-induced changes in brain amine levels. (1962) (14)
Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex (2020) (14)
The dopamine β-hydroxylase inhibitor, nepicastat, reduces different alcohol-related behaviors in rats. (2014) (13)
Evidence for dopamine autoreceptors controlling dopamine synthesis in the substantia nigra (1982) (13)
Reducing effect of the Chinese medicinal herb, Salvia miltiorrhiza, on alcohol self-administration in Sardinian alcohol-preferring rats. (2014) (13)
Different sensitivity to the motor incoordinating effects of γ-hydroxybutyric acid (GHB) and baclofen in GHB-sensitive and GHB-resistant rats (2005) (13)
Reducing Effect of a Combination of Phaseolus vulgaris and Cynara scolymus Extracts on Food Intake and Glycemia in Rats (2013) (13)
GABA(B)-receptor mediation of the inhibitory effect of gamma-hydroxybutyric acid on intestinal motility in mice. (2002) (13)
Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gαi/o protein inhibitor (2018) (13)
Effect of psychotropic drugs on 3,4-dihydroxyphenylacetic acid (DOPAC) content in the medial basal hypothalamus. (1978) (13)
Conditioned place preference induced by ethanol in a rat line selected for ethanol preference. (1990) (13)
Sulpiride and other benzamides : experimental and clinical pharmacology (1979) (13)
Voraciousness induced in cats by benzodiazepines (1976) (13)
Effect of lithium on 3,4-dihydroxyphenylacetic acid (DOPAC) concentrations in different brain areas of rats. (1980) (13)
Suppression of GABAB receptor function in vivo by disulfide reducing agent, dl-dithiothreitol (DTT) (2004) (13)
Anxiolytic Effect of Voluntarily Consumed Alcohol in Sardinian Alcohol-Preferring Rats Exposed to the Social Interaction Test (2013) (12)
Challenges to medications development in treating alcohol dependence: an international perspective. (2004) (12)
Cross-tolerance to ethanol and gamma-hydroxybutyric acid. (1995) (12)
Increase in D2 dopamine receptors in the substantia nigra after chronic (−)-sulpiride treatment (1991) (12)
Up-regulation of GABA(B) receptors by chronic administration of the GABA(B) receptor antagonist SCH 50,911. (2005) (12)
Correlation between amniotic levels of α-MSH, ACTH and β-endorphin in late gestation and labour in normal and complicated pregnancies (1990) (12)
Morphine and β-endorphin antagonize posture and locomotor disorders induced by the injection of ACTH 1–24 in the rat locus coeruleus (1986) (12)
Aphrodisiac effect of p-chlorophenylalanine. (1971) (12)
Prenatal exposure to a cannabinoid receptor agonist does not affect sensorimotor gating in rats. (2006) (12)
Clonidine fails to modify dopaminergic neuronal activity during morphine withdrawal (2001) (12)
Evidence for a dopaminergic control of sympathoadrenal catecholamine release. (1988) (12)
Dopamine-synthesis and tyrosine-hydroxylase are regulated by independent DA-receptor mediated mechanisms. (1978) (12)
Monosodium glutamate does not alter ACTH- or apomorphine-induced penile erection and yawning (1987) (12)
Oxytocin Nasal Spray in the Treatment of Binge Eating Disorder and Obesity: A Pilot, Randomized, Double-Blind Trial (2016) (12)
Anti-addictive properties of COR659 - Additional pharmacological evidence and comparison with a series of novel analogues. (2019) (11)
Differential G-protein coupling to GABAB receptor in limbic areas of alcohol-preferring and -nonpreferring rats. (2005) (11)
Endogenous gamma-hydroxybutyric acid is in the rat, mouse and human gastrointestinal tract. (2003) (11)
Molecular characterization of new polymorphisms at the β2, α1, γ2 GABAA receptor subunit genes associated to a rat nonpreferring ethanol phenotype (2003) (11)
Increase of brain homovanillic acid level induced by metoclopramide (1975) (11)
Characterization of wild-type (R100R) and mutated (Q100Q) GABAA α6 subunit in Sardinian alcohol non-preferring rats (sNP) (2003) (11)
[3H] (-)sulpiride binding in rat striatum, cortex and anterior pituitary: an improved assay. (1987) (11)
Hypothalamic ACTH and MSH levels increase in morphine tolerance and decrease after morphine withdrawal. (1983) (11)
Selective breeding of two rat lines differing in sensitivity to GHB and baclofen (2001) (11)
Levodopa prevents the reinstatement of cocaine self‐administration in rats via potentiation of dopamine release in the medial prefrontal cortex (2018) (11)
Reducing effect of an extract of Phaseolus vulgaris on food intake in mice--focus on highly palatable foods. (2013) (11)
Noradrenergic terminals are the primary source of α2-adrenoceptor mediated dopamine release in the medial prefrontal cortex (2019) (11)
Neuromuscular Blocking Action of some Antibiotics (1959) (11)
Heterogeneous responses of substantia nigra pars reticulata neurons to gamma-hydroxybutyric acid administration. (1993) (11)
Rapid depletion and restoration of striatal met-enkephalin after ketamine. (1981) (10)
Different affinity of cortical GHB binding sites in sardinian alcohol-preferring (sP) and -non preferring (sNP) rats. (1995) (10)
Distribution and Localization of the GABAB Receptor (2016) (10)
Cyclo-oxygenase-inhibitors increase morphine effects on mesolimbic dopamine neurons. (2000) (10)
A differential action of reserpine on brain dopamine stores in rabbit. (1962) (10)
Genetic sensitivity to effect of ethanol on dopaminergic system in alcohol preferring rats. (1991) (10)
Endogenous gamma-aminobutyric acid (GABA)(A) receptor active neurosteroids and the sedative/hypnotic action of gamma-hydroxybutyric acid (GHB): a study in GHB-S (sensitive) and GHB-R (resistant) rat lines. (2005) (10)
T-maze and food reinforcement: an inexpensive drug discrimination procedure (1996) (10)
Voluntary alcohol drinking increases brain dopamine metabolism in rats. (1990) (10)
Effect of apomorphine on human sleep. (1978) (10)
Clozapine does activate nigrostriatal dopamine neurons in unanesthetized rats. (1998) (10)
Role of D1 and α1 receptors in the enhanced locomotor response to dopamine D2-like receptor stimulation induced by repeated electroconvulsive shock (1997) (10)
Protection by the GABAB receptor antagonist, SCH 50911, of gamma-hydroxybutyric acid-induced mortality in mice. (2004) (10)
Procedure of bidirectional selective outbreeding for production of two rat lines differing in sensitivity to the sedative/hypnotic effect of gamma-hydroxybutyric acid. (2001) (10)
Effect of trazodone on brain dopamine metabolism (1976) (10)
α2A adrenergic receptors highly expressed in mesoprefrontal dopamine neurons (2016) (9)
Suppressing effect of saikosaponin A, an active ingredient of Bupleurum falcatum, on chocolate self-administration and reinstatement of chocolate seeking in rats (2017) (9)
gamma-Hydroxybutyric acid (GHB) suppresses alcohol's motivational properties in alcohol-preferring rats. (2008) (9)
Responsiveness to ‘autoreceptor’ doses of apomorphine is inversely correlated with the firing rate of dopaminergic A9 neurons: Action of baclofen (1986) (9)
Anxiolytic effect of an extract of Salvia miltiorrhiza roots in rats (2017) (9)
Reducing effect of saikosaponin A, an active ingredient of Bupleurum falcatum, on alcohol self-administration in rats: Possible involvement of the GABAB receptor (2016) (9)
Resuscitative treatments on 1,4-butanediol mortality in mice. (2006) (9)
Dopamine D(2) receptor antagonists prevent delta(9)-tetrahydrocannabinol-induced antinociception in rats. (1999) (9)
Therapeutical efficacy of a combination of apomorphine with sulpiride or metoclopramide in parkinsonism (1976) (9)
Striato-cerebellar pathway controlling cyclic GMP content in the cerebellum: role of dopamine, GABA and enkephalins. (1978) (9)
Carmoxirole is able to reduce amisulpride-induced hyperprolactinemia without affecting its central effect. (2002) (9)
Haloperidol increases DOPAC in the substantia nigra but not in the ventral tegmental area. (1979) (9)
Co-dergocrine (Hydergine) regulates striatal and hippocampal acetylcholine release through D2 receptors. (1994) (9)
Suppression by γ-Hydroxybutyric Acid of “Alcohol Deprivation Effect” in Rats: Preclinical Evidence of its anti-Relapse Properties (2012) (8)
Long-term lithium treatment and survival from external causes including suicide. (2007) (8)
The cyclo-oxygenase inhibitor nimesulide induces conditioned place preference in rats. (2000) (8)
Risk of thiamine deficiency and Wernicke’s encephalopathy after gastrointestinal surgery for cancer (2015) (8)
Endorphins and sexual behaviour. (1988) (8)
Differential Interaction of 1‐Methyl‐4‐Phenylpyridinium Ion with the Putatively Vesicular Binding Site of [3H]Tyramine in Dopaminergic and Nondopaminergic Brain Regions (1993) (8)
The dopamine β-hydroxylase inhibitor, nepicastat, suppresses chocolate self-administration and reinstatement of chocolate seeking in rats. (2013) (8)
Influence of antibiotics on the neuro-muscular transmission in mammals. (1961) (8)
Evaluation for the Withdrawal Syndrome from γ‐Hydroxybutyric Acid (GHB), γ‐Butyrolactone (GBL), and 1,4‐Butanediol (1,4‐BD) in Different Rat Lines (2006) (8)
Suppressing Effect of the Cannabinoid CB1 Receptor Antagonist, Rimonabant, on Alcohol Self-Administration in Alcohol-Preferring Rats (2009) (8)
Use of the screening suggested by the National Institute on Alcohol Abuse and Alcoholism and of a newly derived tool for the detection of unhealthy alcohol drinkers among surgical patients. (2012) (8)
gamma-Hydroxybutyrate modulation of glutamate levels in the hippocampus: an in vivo and in vitro study. (2001) (8)
570 Failure of ethanol and barbiturates to alter the content of brain 5ht and ne (1961) (8)
High sensitivity to gamma-hydroxybutyric acid in ethanol-preferring sP rats. (1998) (7)
Evaluation for the withdrawal syndrome from gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) in different rat lines. (2006) (7)
Repeated exposure to alcoholic beer does not induce long-lasting changes in alcohol self-administration and intake in Sardinian alcohol-preferring and Sardinian non-preferring rats. (2007) (7)
Cannabinoids activate mesolimbic dopamine neurons by an action on CB1 receptors (1997) (7)
"IN VITRO" ANTIPOLIO ACTIVITY OF METHYLGLYOXALBISGUANYLHYDRAZONE. (1964) (7)
Acid for Treatment of Opiate Withdrawal Syndrome (1993) (7)
Delayed inhibition of dopamine synthesis by gamma-butyrolactone and baclofen: dopamine autoreceptor supersensitivity? (1982) (7)
The effect of D‐ and L‐p‐chlorophenylalanine on the metabolism of 5‐hydroxytryptamine in brain (1973) (7)
Baclofen: preclinical data (2005) (7)
Gamma-hydroxybutyric acid (GHB) for treatment of ethanol dependence (1993) (7)
Withdrawal syndrome from γ-hydroxybutyric acid (GHB) and 1,4-butanediol (1,4-BD) in Sardinian alcohol-preferring rats (2005) (7)
Metadoxine (pyrrolidone carboxylate of pyridoxine) antagonizes the locomotor-stimulatory effect of ethanol in mice. (1992) (7)
Agonist and antagonist actions of lisuride on dopamine neurons: electrophysiological evidence. (1988) (7)
Oxytocin-induced motor disturbances: Relationship with penile erection and yawning (1989) (7)
Completion by the 10th generation of the bidirectional selective breeding of GHB-sensitive and GHB-resistant rats. (2004) (7)
Role of alpha 1 receptors in the behavioural supersensitivity to D2 agonists induced by chronic treatment with imipramine. (1992) (7)
Ipsiversive-cataleptogenic Neurons of Nigra pars Reticulata: Out-put Pathways of Striatal Dopaminergic Responses (1979) (6)
Failure of subchronic lisuride to modify A10 dopamine autoreceptors' sensitivity (1987) (6)
Poliovirus: Guanidine Dependence and Loss of Neurovirulence for Monkeys (1964) (6)
Elevated reinforcing and motivational properties of alcohol at the end of the nocturnal period in sP rats (2015) (6)
Increased lipolytic response to norepinephrine in isolated brown fat cells after sympathetic denervation. (1970) (6)
Is in vivo striatal acetylcholine output under a tonic inhibitory control by dopamine? (1995) (6)
Clonidine Prevents Corticotropin Releasing Factor‐Induced Epileptogenic Activity in Rats (1992) (6)
Different effects of the calcium antagonists nimodipine and flunarizine on dopamine metabolism in the rat brain (2005) (6)
Effect of the amisulpride isomers on rat prolactinemia. (2002) (6)
Preprotachykinin-A gene expression in the forebrain of Sardinian alcohol-preferring and -nonpreferring rats. (1998) (6)
Ethanol, at micromolar concentrations, increases the affinity of [3H]MK-801 binding in rat brain. (1991) (6)
Withdrawal syndrome from gamma-hydroxybutyric acid (GHB) and 1,4-butanediol (1,4-BD) in Sardinian alcohol-preferring rats. (2005) (6)
Long-term exposure to a sweetened alcoholic solution does not alter genetic aversion to ethanol in Sardinian alcohol-nonpreferring (sNP) rats. (2003) (6)
Naloxone shortens ejaculation latency in male rats (1979) (6)
Bromocriptine reduces plasma noradrenaline and 3,4-dihydroxyphenylacetic acid in normal and hypotensive subjects (2004) (6)
In vitro evidence for the presence of [3H]‐haloperidol uptake in rat brain (2003) (6)
Tawning: Neurochemistry, Physiology And Pathology (1987) (6)
SCH 23390 and psychosis (1991) (6)
[3H]Tyramine binding: A comparison with neuronal [3H]-dopamine uptake and [3H]mazindol binding processes (1989) (6)
Correlation between amniotic levels of alpha-MSH, ACTH and beta-endorphin in late gestation and labour in normal and complicated pregnancies. (1990) (6)
Parkinsonism by haloperidol and piribedil (1978) (5)
Naloxone antagonizes ethanol- but not gamma-hydroxybutyrate-induced sleep in mice. (1994) (5)
Title Anxiolytic-like properties of the anandamide transport inhibitor AM 404 Permalink (2006) (5)
Opioid-dopamine interactions in stress-induced insomnia (1987) (5)
Cannabinoid receptor antagonists: a perspective (2005) (5)
Stereoselectivity of NCS-382 binding to gamma-hydroxybutyrate receptor in the rat brain. (2002) (5)
Haloperidol-induced vacuous chewing in rats: suppression by alpha-methyl-tyrosine. (1992) (5)
Novel pharmacotherapies and patents for alcohol abuse and alcoholism 1998-2001 (2001) (5)
On the mechanism of norepinephrine release by alpha-methyl-metaty-rosine. (1962) (5)
Suppression of ethanol intake in ethanol-preferring rats by 1,4-butanediol. (1990) (5)
SKF 38393, a selective D1 DA agonist, induces penile erection in rats (1988) (5)
Characterization of the discriminative stimulus effects of gamma-hydroxybutyric acid as a means for unraveling the neurochemical basis of gamma-hydroxybutyric acid actions and its similarities to those of ethanol. (2000) (4)
Potent, extra-channel influence of several calcium-channel modulators on striatal binding of [3H]tyramine (1993) (4)
Molecular characterization of new polymorphisms at the beta2, alpha1, gamma2 GABA(A) receptor subunit genes associated to a rat nonpreferring ethanol phenotype. (2003) (4)
Effect of chronic treatment with neuroleptics on the content of 3',5'-cyclic guanosine monophosphate in cerebellar cortex of rats. (1978) (4)
Aminophylline antagonizes diazepam-induced anesthesia and EEG changes in humans (2004) (4)
Blockade of DA autoreceptors: possible mechanism of antidepressant action of L-Sulpiride (1990) (4)
Reducing Effect of Saikosaponin A, an Active Ingredient of Bupleurum falcatum, on Intake of Highly Palatable Food in a Rat Model of Overeating (2018) (4)
METOCLOPRAMIDE AND DYSTONIC REACTIONS IN SARDINIANS (1979) (4)
Binge drinking and anxiety at the end of the nocturnal period in alcohol-preferring sP rats. (2017) (4)
Homovanillic and 5-Hydroxyindeleacetic Acids in Cerebrospinal Fluid After Probenecid: Measurement of Brain Monoamine Oxidase Inhibition in Vivo (1970) (4)
Inhibition of voluntary ethanol intake in rats by a combination of dihydroergotoxine and thioridazine. (1987) (4)
Association between reserpine syndrome and blockade of brain serotonin storage processes. (1962) (4)
Suppression of acquisition of alcohol-drinking behavior by the concurrent availability of saccharin in Sardinian alcohol-preferring (sP) rats. (2005) (4)
Chronic administration of l-sulpiride at low doses reduces A10 but not A9 somatodentritic dopamine autoreceptor sensitivity. (1996) (4)
Relationship between Cannabinoid CB1 and Dopamine D2 Receptors in Intestinal Motility in Mice (2000) (4)
Suppression of maintenance of alcohol-drinking behavior by the concurrent availability of saccharin in Sardinian alcohol-preferring (sP) rats. (2005) (4)
[Role of tryptophan in the physiological regulation of brain serotonin synthesis (author's transl)]. (1975) (4)
γ-Hydroxybutyric Acid (GHB) (2010) (3)
Suppressing effect of the novel positive allosteric modulator of the GABAB receptor, COR659, on locomotor hyperactivity induced by different drugs of abuse (2020) (3)
Decrease of cyclic GMP in cerebellum by intrastriatal D-Ala2-met-enkephalinamide. (1978) (3)
dolescent Exposure to Cannabinoids Induces ong-Lasting Changes in the Response to Drugs of buse of Rat Midbrain Dopamine Neurons (2004) (3)
Selective c-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus , but fail to activate G protein and to produce the sedative / hypnotic effect of c-hydroxybutyric acid (2003) (3)
A Phaseolus vulgaris Extract Reduces Cue-Induced Reinstatement of Chocolate Seeking in Rats (2016) (3)
Accelerated synthesis of dopamine in the rat brain after methadone (1972) (3)
Reducing Effect of Cannabidiol on Alcohol Self-Administration in Sardinian Alcohol-Preferring Rats. (2021) (3)
Apomorphine-induced sedation: an animal model of mental depression. (1980) (3)
Baclofen: clinical data (2005) (3)
Effect of isradipine, a dihydropyridine-calcium antagonist on i.v. self-administration of morphine in rats. (1996) (3)
Rat tyrosine hydroxylase gene polymorphisms. (1997) (3)
The long pursued Holy Grail of the true “alcoholic” rat (2016) (3)
Tolerance to haloperidol effect on dopamine (DA) synthesis is independent from postsynaptic DA receptors. (1980) (3)
Reducing effect of the novel positive allosteric modulator of the GABAB receptor, COR659, on binge-like alcohol drinking in male mice and rats (2021) (3)
Differential Effects of Saikosaponins A, B2, B4, C and D on Alcohol and Chocolate Self-Administration in Rats. (2020) (3)
Phencyclidine decreases methionine-enkephalin content in rat striatum (1983) (3)
Gamma-hydroxybutyric acid versus alcohol preference in Sardinian alcohol-preferring rats. (2002) (2)
GABA-receptors in the substantia nigra controlling cyclic-GMP in the cerebellar cortex. (1979) (2)
2322 – I STRESS-INDUCED INCREASE IN 3,4-DIHYDROXYPHENYLACETIC ACID (DOPAC) IN THE CERE-3RAL CORTEX AND n. ACCUMBENS: REVERSAL BY DIAZEPAM (1978) (2)
Unawareness of Alcoholic Content of Alcopops among 13-Year Old Italian Teenagers (2013) (2)
Reduction of blood ethanol levels by the gamma-hydroxybutyric acid receptor antagonist, NCS-382. (1999) (2)
Differential effects of kainic acid on benzodiazepine receptors, GABA receptors, and GABA-modulin in the cerebellar cortex. (1980) (2)
Disulfiram inhibits chocolate self-administration and reinstatement to chocolate seeking in rats (2016) (2)
Preface to the proceedings of the third Soviet-Italian Joint Meeting on Neurotransmitters and Brain Function (1980) (2)
Does chronic imipramine facilitate neurotransmission at dopamine-D1 receptor level? (1989) (2)
Kainic acid-induced lesion of dopaminergic target cells in the striatum: Consequences on the dynamics of cerebellar cGMP (1978) (2)
Exposure to an enriched environment reduces alcohol self-administration in Sardinian alcohol-preferring rats (2022) (2)
The Novel Positive Allosteric Modulator of the GABAB Receptor, KK-92A, Suppresses Alcohol Self-Administration and Cue-Induced Reinstatement of Alcohol Seeking in Rats (2021) (2)
Ethanol-induced place preference in naive alcohol-preferring rats (1990) (2)
[Peripheral presynaptic dopamine receptors control the release of norepinephrine and arterial pressure in humans]. (1987) (2)
Fidia and neuroscience (1993) (2)
192 – INHIBITION BY APOMORPHINE OF DOPAMINE DEAMINATION, O-METHYLATION AND UPTAKE BY THE RAT BRAIN (1977) (2)
INHIBITING ACTIVITY OF SULPHONIAZIDE AGAINST POLIOVIRUS AND VACCINIA VIRUS. (1964) (2)
Evaluation of cortical and hippocampal acetylcholine release during the sleep-wake cycle in freely moving cats: and EEG-dialysis study (1995) (2)
Differential postmortem release of noradrenaline and dopamine from rat brain (2004) (1)
Molecular genetics and expression of dopamine gene receptors in a rat line selected for ethanol preference (1995) (1)
Marked increase of peripheral dopamine metabolism in congestive heart failure in man (1988) (1)
Marked increase of plasma 3,4-dihydroxyphenylacetic acid in congestive heart failure. (1984) (1)
Evidence That the Rise in Temperature Produced by d -Amphetamine is Caused by a Peripheral Action of the Drug (1969) (1)
Subject Index Vol. 16 (suppl 1), 1978 (1978) (1)
INHIBITION OF BASAL AND STRESS-INDUCED DOPAMINE RELEASE IN THE CEREBRAL CORTEX AND NUCLEUS ACCUMBENS OF FREELY MOVING RATS BY THE NEUROSTEROID ALLOPREGNANOLONE (1996) (1)
Dopamine and mental depression : proceedings of the Biannual Capo Boi Conference on Neuroscience, June 1989, Villasimius, Italy (1990) (1)
Failure of Prolactin to Inhibit Sexual Behavior in the Male Rat (1983) (1)
GHB-C rats: the control line of GHB-sensitive (GHB-S) and GHB-resistant (GHB-R) rats. (2005) (1)
Dopamine receptor gene expression in rat lines selected for ethanol preference or aversion: 2.3 (1995) (1)
Changes in gastro-intestinal serotonin content associated with fasting and satiation (1977) (1)
Evidence that the loss of brain catecholamine stores due to blockade of storage does not cause sedation. (1962) (1)
[Experimental models of alcoholism]. (1990) (1)
A note on the subcellular distribution of adipose tissue noradrenaline (1968) (1)
Positive association between dopamine D2 receptor gene and migraine without aura in a Sardinian sample (2000) (1)
Failure of (-) sulpiride to inibit sexual behavior in rats (1979) (1)
1148 – SELECTIVE BLOCKADE OF THE EMETIC EFFECT OF APOMORPHINE BY METOCLOPRAMIDE AND SULPIRIDE (1977) (1)
[Significance of metabolites of cerebral monoamines in relation to neuronal function]. (1976) (1)
Cue-induced reinstatement of ethanol seeking behaviour in Sardinian alcohol preferring rats (sP) rats (2007) (1)
Use of Medications for the Treatment of Alcohol Dependence: A Retrospective Study Conducted in 2011-2012. (2020) (1)
Self-inhibitory dopamine-receptors and central effects of apomorphine. (1978) (1)
Gender Differences among Sardinians with Alcohol Use Disorder (2021) (1)
Role of striatal dopamine receptors in the regulation of cerebellar cyclic GMP. (1978) (1)
Elevated reinforcing and motivational properties of alcohol at the end of the nocturnal period in sP rats (2015) (0)
NEUROCHEMICAL BASIS FOR ALCOHOL PREFERENCE AND RELATED BEHAVIORS (1999) (0)
S-12-1 Animal models in alcohol research (1995) (0)
A pharmaceutical composition comprising gamma-hydroxybutyric acid or the corresponding lactone, for the treatment of drug addiction and eating disorders (1992) (0)
Contents Vol. 19, 2013 (2013) (0)
Role of the anandamide reuptake inhibitor AM404 in the modulation of emotional reactivity in rats (2005) (0)
Disulfiram reduces cocaine self - administration in rats (2003) (0)
Role of dopamine in alcohol reinforcement and withdrawal syndrome (1992) (0)
Is 2‐Hydroxypropyl‐β‐cyclodextrin a Suitable Carrier for Central Administration of Δ9‐Tetrahydrocannabinol? Preclinical Evidence (2017) (0)
EXPERIMENTAL DRUG ADDICTION SELECTIVELY ALTERS BRAIN OPIOID RECEPTOR BINDING IN RAT (1996) (0)
Persistent increase in CB1 receptor and amnestic effect of cannabinoid by methamphetamine (2009) (0)
Blockade of the GABAB receptor suppressed alcohol self-administration in rats: an effect similar to that produced by GABAB receptor activation (2021) (0)
Evidence for D2-Dopamine Receptors Modulating Noradrenaline Release in the Rat Frontal Cortex (1991) (0)
Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent subjects after single and repeated oral administration (1992) (0)
Lack of tolerance to the suppressing effect of rimonabant on intake of a highly palatable food in rats (2006) (0)
Hormonal interference in experimental models of depression. (1982) (0)
[Potentiation by monoamine oxidase inhibitors of the pressor effect of tyramine and of alpha-methyl-m-tyramine]. (1964) (0)
INVOLVEMENT OF CANNABINOID CB1 AND GABAB RECEPTORS IN THE CONTROL OF RELAPSE-LIKE DRINKING IN ALCOHOL-PREFERRING SP RATS. (2004) (0)
Investigation on the relationship between cannabinoid CB1 and opioid receptors in gastrointestinal motility in mice (2007) (0)
Endocannabinoids mediate pre-synaptic inhibition of glutamatergic transmission in rat VTA DA neurons through activation of CB1 receptors (2004) (0)
[BRETYLIUM-LIKE ACTION OF A MONOAMINE OXIDASE INHIBITOR]. (1963) (0)
Use of gamma-hydroxysmørsyresalte for the preparation of pharmaceutical compositions for the treatment of alcoholism (1989) (0)
THE ROLE OF CANNABINOID RECEPTORS IN THE CONTROL OF ALCOHOL INTAKE. (2004) (0)
MELANOTROPINS: FROM SKIN TO BRAIN, A LONG JOURNEY ALONG PHYLOGENESIS (1996) (0)
Behavioural supersensitivity to Da agonists induced by chronic treatment with antidepressants: role of NMDA receptors. (1993) (0)
Foerfarande Foer framstaellning of Foer of pharmaceutical compositions have at anvaendning Treatment of Alcoholism. (1989) (0)
Use of agonists of GABA B receptors and pharmaceutically acceptable derivatives thereof for the treatment to achieve continued nicotine abstinence in nicotine-dependent patients (2000) (0)
P288: Uterine arteries Doppler in patients hospitalised for preeclampsia (2003) (0)
Dietary supplement for influencing of sleep. (1984) (0)
[Characterization of the muscle paralyzing effect of tetracycline]. (1960) (0)
[Relation between antibiotics and curarism. III. Tetracycline and curarism]. (1960) (0)
ACTH-Derived Neuropeptides and Dopamine Interaction in the Control of Penile Erection. (1988) (0)
S-74-5 Gamma-hydroxybutyric acid: A “methadone” for alcoholism? (1996) (0)
Preface to the Special Issue (2000) (0)
Diaettilskud with a specific foroegende effect on human stage 4 sleep (1984) (0)
Front & Back Matter (2013) (0)
Cycloheximide blocks apomorphine-induced penile erection, yawning and genital grooming. (1982) (0)
[Independence of the effects of a selective acetylcholinesterase inhibitor (CT 3318) on striated muscle from its antienzymatic activity]. (1959) (0)
[Guidelines for the drug therapy of alcoholism]. (1990) (0)
Action of N‐o‐Chlorobenzyl‐N′N″‐dimethylguanidine (BW 392C60), a bretylium‐like drug in lowering the intraocular pressure of rabbit eyes (1964) (0)
Role of GABA receptors in the sedativerhypnotic (2001) (0)
Environmental Enrichment Augments Binge-Like Alcohol Drinking In Sardinian Alcohol-Preferring Rats. (2022) (0)
SACCHARIN AVAILABILITY PREVENTS THE ACQUISITION OF ALCOHOL DRINKING BEHAVIOR IN ALCOHOL-PREFERRING sP RATS. (2004) (0)
234 Neurochemistry of pleasure and de-spair (1998) (0)
1303 – EXTRAPIRAMIDAL EFFECTS OF INTRA-THALAMIC INJECTION OF MUSCIMOL AND PICROTOXIN (1978) (0)
2062 – THALAMIC GABA RECEPTORS REGULATE CEREBELLAR CYCLIC GMP: EFFECT OF MUSCIMOL AND PICROTOXIN (1978) (0)
Disulfiram stimulates dopamine release from noradrenergic terminals and potentiates cocaine-induced dopamine release in the prefrontal cortex (2011) (0)
Inhibition of alcohol self-administration by positive allosteric modulators of the GABAB receptor in rats: lack of tolerance and potentiation of baclofen (2014) (0)
Use of gamma-hydroxysmoersyresalte for the manufacture of pharmaceutical preparations for the treatment of alcoholism and preparations thus obtained (1989) (0)
Foreword. The clinical aspects of deficit in dopaminergic ways. (2002) (0)
[Protamine potentiation of the effects of muscle relaxants]. (1959) (0)
Effect of methadone and other narcotic analgesics on brain dopamine metabolism (1973) (0)
The potent α2-adrenoceptor antagonist RS 79948 also inhibits dopamine D2 -receptors: Comparison with atipamezole and raclopride (2022) (0)
Antiinductores use of GABAB receptors and pharmaceutically acceptable derivatives thereof, in maintenance therapy of nicotine abstinence in nicotine-dependent patients. (2000) (0)
Role of GABA receptors in the sedative r hypnoticB effect of g-hydroxybutyric acid (2001) (0)
Neurosteroids and alcohol action (2001) (0)
2361 – EFFECT OF p-CHLOROPHENYL GABA ON MONOAMINE METABOLISM IN RAT: TRYPTOPHAN DISPLACEMENT FROM ALBUMIN BINDING SITES (1978) (0)
Dopamine hypothensis of affective disorders: Behavioural, Biochemical and Electrophysiological evidences from chronic treatment with antidepressants. (1984) (0)
Neurochemical profile of amiridime - A new drug for dementia treatment (1995) (0)
Effects of tiapride on homovanillic acid levels in human cerebrospinal fluid drawn at pneumoencephalography (2004) (0)
Delineating the Psychic Structure of Substance Use and Addictions, from Neurobiology to Clinical Implications: Ten Years Later (2020) (0)
Suppressing effect of COR659 on alcohol, sucrose, and chocolate self-administration in rats: involvement of the GABAB and cannabinoid CB1 receptors (2017) (0)
g-Hydroxybutyrate modulation of glutamate levels in the hippocampus : an in vivo and in vitro study (2001) (0)
Exacerbation of the inherent “anxiety” state by unpredictability of alcohol access in Sardinian alcohol-preferring rats (2017) (0)
SPECIAL ISSUE ARTICLE SUPPRESSING EFFECT OF THE CANNABINOID CB 1 RECEPTOR ANTAGONIST, SR147778, ON ALCOHOL INTAKE AND MOTIVATIONAL PROPERTIES OF ALCOHOL IN ALCOHOL-PREFERRING SP RATS (2005) (0)
Differential post-mortem release of noradrenaline and dopamine: a re-evaluation (2005) (0)
[Antagonism by demethylimipramine of the adrenergic effect of tyramine]. (1965) (0)
476 Chronic activation of CB1 receptors fails to impair sensorimotor gating in rodents (2003) (0)
[Relation between antibiotics and curarism]. (1960) (0)
Effects of 7-OH-DPAT on the rat mesolimbic dopaminergic system: 15.2 (1995) (0)
P 11 Endocannabinoids in chronic alcoholic liver disease (2017) (0)
[Relation between antibiotics and curarism. II. Pencicilin and chloramphenicol and curarism]. (1960) (0)
S.14.05 Place for baclofen in treating alcoholism (2010) (0)
Development of tolerance upon repeated administration with the GABAB receptor positive allosteric modulator, COR659, on alcohol drinking in rodents (2022) (0)
The inverse agonistic effect of Rimonabant is not mediated by CB1, GABAB, opiod and D2 dopamine receptors. (2014) (0)
451 – INDUCTION OF COPULATORY BEHAVIOR IN IMPOTENT RATS BY NALOXONE (1978) (0)
Allopregnanolone and THDOC brain concentrations in Sardinian alcohol-preferring (sP) rats (1999) (0)
Interactive report Cannabinoid receptor CB mRNA is highly expressed in the rat ciliary (1998) (0)

This paper list is powered by the following services:

Other Resources About Gian Luigi Gessa

en.wikipedia.org

What Schools Are Affiliated With Gian Luigi Gessa?

Gian Luigi Gessa is affiliated with the following schools:

University of Cagliari

Image Attributions

Image Source for Gian Luigi Gessa